Top 10 most-read articles of the year 2023
Pharmaceutical patent cases and medical devices lead the JUVE Patent most-read top ten this year, with readers taking a specific interest in topics such as DNA sequencing technology, heart valves and insulin pumps - all of which have tangible real-world applications. Just like in 2022, the drug apixaban continued to be a popular topic for readers, while aspects of the global dispute around mRNA vaccines features twice in this year's top ten. Perhaps surprisingly, however, the UPC and SEPs feature just once, together, in a story concerning the battle between Panasonic, Oppo and Xiaomi. The much-talked about European Patent Office decision regarding plausibility rounds off the final count for 2023.
27 December 2023 by Amy Sandys
These are the top ten most-read articles by JUVE Patent readers in 2023:
1. Illumina loses more patents for DNA-sequencing technology
2. Insulet and Peterreins Schley win PI over insulin pumps at Düsseldorf Regional Court
3. Court of Appeal confirms invalidity of Bristol-Myers Squibb apixaban patent
4. EPO revokes Moderna patent in vaccine dispute with BioNTech
5. EPO revokes Novartis everolimus patent in major victory for generics companies
6. Edwards stumbles against Meril as heart-valve dispute reaches the Netherlands
7. Panasonic and Kather Augenstein launch first major SEP campaign at UPC against Oppo and Xiaomi
8. Moderna targets Ireland and Belgium in next round against Pfizer and BioNTech
9. G 2/21: Enlarged Board of Appeal allows post-filed data to prove technical effect
10. BAT draws level with Philip Morris after success in London and Düsseldorf